|Bid||0.0050 x 0|
|Ask||0.0065 x 0|
|Day's Range||0.0050 - 0.0050|
|52 Week Range||0.0050 - 0.0354|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Insiders who acquired AU$300k worth of Creso Pharma Limited's ( ASX:CPH ) stock at an average price of AU$0.04 in the...
Creso Pharma ( ASX:CPH ) Full Year 2022 Results Key Financial Results Revenue: AU$9.03m (up 45% from FY 2021). Net...
Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc. ('Halucenex'), is exploring opportunities to register its synthetic psilocybin formulation for the Australian market following recent regulatory changes.